Derek Price
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial.
Journal: European urology oncology
Published: March 03, 2025
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: January 23, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Journal: The Lancet. Oncology
Published: December 20, 2024
Prostate Assessment using Comparative Interventions - Fast MRI and Image-fusion for Cancer (IP7-PACIFIC): A prospective, multi-centre, dual sequential randomised controlled trial.
Journal: Contemporary clinical trials
Published: October 28, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.
Journal: The New England journal of medicine
Published: October 16, 2024
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study.
Journal: Prostate cancer and prostatic diseases
Published: May 29, 2022
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study.
Journal: European urology oncology
Published: November 24, 2021
Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening.
Journal: Journal of clinical epidemiology
Published: October 30, 2021
Last Updated: 09/26/2026